The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
Open accessAbstract
β-catenin (encoded by CTNNB1) is a subunit of the cell surface cadherin protein complex that acts as an intracellular signal transducer in the WNT signaling pathway; alterations in its activity have been associated with the development of hepatocellular carcinoma and other liver diseases. Other than WNT, additional signaling pathways also can converge at β-catenin. β-catenin also interacts with transcription factors such as T-cell factor, forkhead box protein O, and hypoxia inducible factor 1α to regulate the expression of target genes. We discuss the role of β-catenin in metabolic zonation of the adult liver. β-catenin also regulates the expression of genes that control metabolism of glucose, nutrients, and xenobiotics; alterations in its activity may contribute to the pathogenesis of nonalcoholic steatohepatitis. Alterations in β-catenin signaling may lead to activation of hepatic stellate cells, which is required for fibrosis. Many hepatic tumors such as hepatocellular adenomas, hepatocellular cancers, and hepatoblastomas have mutations in CTNNB1 that result in constitutive activation of β-catenin, so this molecule could be a therapeutic target. We discuss how alterations in β-catenin activity contribute to liver disease and how these might be used in diagnosis and prognosis, as well as in the development of therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Regulation of β-Catenin Structure and Activity by Tyrosine Phosphorylation
Piedra, J., Martı́nez, D., Castaño, J., Miravet, S., Duñach, M., & de Herreros, A. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100194200 · Cited by 262
RetractedSpirlì, C., Locatelli, L., Morell, C. M., Fiorotto, R., Morton, S. D., Cadamuro, M., Fabris, L., & Strazzabosco, M. (2013) · Hepatology · doi:10.1002/hep.26554 · Cited by 49
RetractedSorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
Inhibition of Adipogenesis by Wnt Signaling
Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L., & MacDougald, O. A. (2000) · Science · doi:10.1126/science.289.5481.950 · Cited by 1,874
Functional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β
Behrens, J., Jerchow, B.-A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D., & Birchmeier, W. (1998) · Science · doi:10.1126/science.280.5363.596 · Cited by 1,260
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context
Mikels, A. J., & Nusse, R. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040115 · Cited by 1,252
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960
Behrens, J., Vakaet, L., Friis, R., Winterhager, E., Van Roy, F., Mareel, M. M., & Birchmeier, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.3.757 · Cited by 904
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., Moon, R. T., Teo, J.-L., Oh, S. W., Kim, H. Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404875101 · Cited by 874
Huber, A. H., & Weis, W. I. (2001) · Cell · doi:10.1016/s0092-8674(01)00330-0 · Cited by 777
Bänziger, C., Soldini, D., Schütt, C., Zipperlen, P., Hausmann, G., & Basler, K. (2006) · Cell · doi:10.1016/j.cell.2006.02.049 · Cited by 764
Zucman-Rossi, J., Jeannot, E., Van Nhieu, J. T., Scoazec, J.-Y., Guettier, C., Rebouissou, S., Bacq, Y., Leteurtre, E., Paradis, V., Michalak, S., et al. (2006) · Hepatology · doi:10.1002/hep.21068 · Cited by 760
Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway
Amit, S., Hatzubai, A., Birman, Y., Andersen, J. S., Ben-Shushan, E., Mann, M., Ben-Neriah, Y., & Alkalay, I. (2002) · Genes & Development · doi:10.1101/gad.230302 · Cited by 753
Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling
Essers, M. A. G., de Vries-Smits, L. M. M., Barker, N., Polderman, P. E., Burgering, B. M. T., & Korswagen, H. C. (2005) · Science · doi:10.1126/science.1109083 · Cited by 745
Hoschuetzky, H., Aberle, H., & Kemler, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.5.1375 · Cited by 711
Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
Goessling, W., North, T. E., Loewer, S., Lord, A. M., Lee, S., Stoick-Cooper, C. L., Weidinger, G., Puder, M., Daley, G. Q., Moon, R. T., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.015 · Cited by 699
Nault, J. C., Mallet, M., Pilati, C., Calderaro, J., Bioulac-Sage, P., Laurent, C., Laurent, A., Cherqui, D., Balabaud, C., & Zucman-Rossi, J. (2013) · Nature Communications · doi:10.1038/ncomms3218 · Cited by 695
Lok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.014 · Cited by 651
Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin.
Knudsen, K. A., Soler, A. P., Johnson, K. R., & Wheelock, M. J. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.1.67 · Cited by 650
Secreted and transmembrane wnt inhibitors and activators
Cruciat, C.-M., & Niehrs, C. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015081 · Cited by 646
Regulation of E-cadherin/Catenin Association by Tyrosine Phosphorylation
Roura, S., Miravet, S., Piedra, J., de Herreros, A. G., & Duñach, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36734 · Cited by 603
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry
Bioulac-Sage, P., Rebouissou, S., Thomas, C., Blanc, J.-F., Saric, J., Sa Cunha, A., Rullier, A., Cubel, G., Couchy, G., Imbeaud, S., et al. (2007) · Hepatology · doi:10.1002/hep.21743 · Cited by 590
Secretion of Wnt Ligands Requires Evi, a Conserved Transmembrane Protein
Bartscherer, K., Pelte, N., Ingelfinger, D., & Boutros, M. (2006) · Cell · doi:10.1016/j.cell.2006.04.009 · Cited by 580
Wnt/β-Catenin Signaling Promotes Renal Interstitial Fibrosis
He, W., Dai, C., Li, Y., Zeng, G., Monga, S. P., & Liu, Y. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060566 · Cited by 549
Self-citationApc Tumor Suppressor Gene Is the “Zonation-Keeper” of Mouse Liver
Benhamouche, S., Decaens, T., Godard, C., Chambrey, R., Rickman, D. S., Moinard, C., Vasseur-Cognet, M., Kuo, C. J., Kahn, A., Perret, C., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.015 · Cited by 543
Brannon, M., Gomperts, M., Sumoy, L., Moon, R. T., & Kimelman, D. (1997) · Genes & Development · doi:10.1101/gad.11.18.2359 · Cited by 522
Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia
Kaidi, A., Williams, A. C., & Paraskeva, C. (2007) · Nature Cell Biology · doi:10.1038/ncb1534 · Cited by 517
Cairo, S., Armengol, C., De Reyniès, A., Wei, Y., Thomas, E., Renard, C.-A., Goga, A., Balakrishnan, A., Semeraro, M., Gresh, L., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.002 · Cited by 509
Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas
Taniguchi, K., Roberts, L. R., Aderca, I. N., Dong, X., Qian, C., Murphy, L. M., Nagorney, D. M., Burgart, L. J., Roche, P. C., Smith, D. I., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205591 · Cited by 486
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477
Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer
Nishita, M., Hashimoto, M. K., Ogata, S., Laurent, M. N., Ueno, N., Shibuya, H., & Cho, K. W. Y. (2000) · Nature · doi:10.1038/35001602 · Cited by 465
Synergy Between Tumor Suppressor APC and the β-Catenin-Tcf4 Target Tcf1
Roose, J., Huls, G., Beest, M. V., Moerer, P., Horn, K. V. D., Goldschmeding, R., Logtenberg, T., & Clevers, H. (1999) · Science · doi:10.1126/science.285.5435.1923 · Cited by 456
O2 regulates stem cells through Wnt/β-catenin signalling
Mazumdar, J., O'Brien, W. T., Johnson, R. S., LaManna, J. C., Chavez, J. C., Klein, P. S., & Simon, M. C. (2010) · Nature Cell Biology · doi:10.1038/ncb2102 · Cited by 454
Phosphorylation of β-Catenin by Cyclic AMP-dependent Protein Kinase
Taurin, S., Sandbo, N., Qin, Y., Browning, D., & Dulin, N. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508778200 · Cited by 449
Zhang, T., Otevrel, T., Gao, Z., Gao, Z., Ehrlich, S. M., Fields, J. Z., & Boman, B. M. (2001) · PubMed · Cited by 441
LEF-1, a Nuclear Factor Coordinating Signaling Inputs from wingless and decapentaplegic
Riese, J., Yu, X., Munnerlyn, A., Eresh, S., Hsu, S.-C., Grosschedl, R., & Bienz, M. (1997) · Cell · doi:10.1016/s0092-8674(00)81924-8 · Cited by 439
Hino, S.-I., Tanji, C., Nakayama, K. I., & Kikuchi, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.9063-9072.2005 · Cited by 427
Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.
Zhang, X., Gaspard, J. P., & Chung, D. C. (2001) · PubMed · Cited by 427
Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Oku, N., Miyazawa, K., Kitanfura, N., Takeichi, M., & Ito, F. (1994) · Cell Adhesion and Communication · doi:10.3109/15419069409097261 · Cited by 414
New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
Cadoret, A., Ovejero, C., Terris, B., Souil, E., Lévy, L., Lamers, W. H., Kitajewski, J., Kahn, A., & Perret, C. (2002) · Oncogene · doi:10.1038/sj.onc.1206118 · Cited by 410
Koch, A., Denkhaus, D., Albrecht, S., Leuschner, I., von Schweinitz, D., & Pietsch, T. (1999) · PubMed · Cited by 399
Yan, D., Wiesmann, M., Rohan, M., Chan, V., Jefferson, A. B., Guo, L., Sakamoto, D., Caothien, R. H., Fuller, J. H., Reinhard, C., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261574498 · Cited by 366
Conditional Deletion of β-Catenin Reveals Its Role in Liver Growth and Regeneration
Tan, X., Behari, J., Cieply, B., Michalopoulos, G. K., & Monga, S. P. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.042 · Cited by 361
Self-citationBi-allelic inactivation of TCF1 in hepatic adenomas
Bluteau, O., Jeannot, E., Bioulac-Sage, P., Marqués, J. M., Blanc, J.-F., Bui, H., Beaudoin, J.-C., Franco, D., Balabaud, C., Laurent-Puig, P., et al. (2002) · Nature Genetics · doi:10.1038/ng1001 · Cited by 353
Wong, C. M., Fan, S. T., & Ng, I. O. L. (2001) · Cancer · doi:10.1002/1097-0142(20010701)92:1<136::aid-cncr1301>3.0.co;2-r · Cited by 348
Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex.
Jou, T. S., Stewart, D. B., Stappert, J., Nelson, W. J., & Marrs, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5067 · Cited by 333
Colnot, S., Decaens, T., Niwa-Kawakita, M., Godard, C., Hamard, G., Kahn, A., Giovannini, M., & Perret, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404761101 · Cited by 328
Tao, J., Calvisi, D. F., Ranganathan, S., Cigliano, A., Zhou, L., Singh, S., Jiang, L., Fan, B., Terracciano, L., Armeanu–Ebinger, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.004 · Cited by 317
Self-citationMonga, S. P., Mars, W. M., Pediaditakis, P., Bell, A. W., Mulé, K., Bowen, W. C., Wang, X., Zarnegar, R., & Michalopoulos, G. K. (2002) · PubMed · Cited by 304
Self-citationHepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical Care
Nault, J., Bioulac–Sage, P., & Zucman–Rossi, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.032 · Cited by 299
Nhieu, J. T. V., Renard, C. A., Wei, Y., Cherqui, D., Zafrani, E. S., & Buendia, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65168-1 · Cited by 295
Sekine, S., Lan, B. Y., Bedolli, M., Feng, S., & Hebrok, M. (2006) · Hepatology · doi:10.1002/hep.21131 · Cited by 295
Hsu, H.-C., Jeng, Y.-M., Mao, T.-L., Chu, J.-S., Lai, P.-L., & Peng, S.-Y. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64590-7 · Cited by 294
Huang, H., Fujii, H., Sankila, A., Mahler-Araujo, B. M., Matsuda, M., Cathomas, G., & Ohgaki, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65496-x · Cited by 274
Pilati, C., Letouzé, E., Nault, J.-C., Imbeaud, S., Boulai, A., Calderaro, J., Poussin, K., Franconi, A., Couchy, G., Morcrette, G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.005 · Cited by 272
Interaction of FOXO with β-Catenin Inhibits β-Catenin/T Cell Factor Activity
Hoogeboom, D., Essers, M. A. G., Polderman, P. E., Voets, E., Smits, L. M. M., & Burgering, B. M. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706638200 · Cited by 271
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad
Nejak-Bowen, K. N., & Monga, S. P. S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.010 · Cited by 260
Self-citationCharacterization of the interactions of α-catenin with α-actinin and β-catenin/plakoglobin
Nieset, J. E., Redfield, A. R., Jin, F., Knudsen, K. A., Johnson, K. R., & Wheelock, M. J. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.8.1013 · Cited by 260
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
Cheng, J. H., She, H., Han, Y.-P., Wang, J., Xiong, S., Asahina, K., & Tsukamoto, H. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00263.2007 · Cited by 258
Zucman-Rossi, J., Benhamouche, S., Godard, C., Boyault, S., Grimber, G., Balabaud, C., Cunha, A. S., Bioulac-Sage, P., & Perret, C. (2007) · Oncogene · doi:10.1038/sj.onc.1209824 · Cited by 256
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma
Merle, P., de la Monte, S., Kim, M., Herrmann, M., Tanaka, S., Von Dem Bussche, A., Kew, M. C., Trepo, C., & Wands, J. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.009 · Cited by 249
Wanless, I. R., Albrecht, S., Bilbao, J., Frei, J., Heathcote, E. J., Roberts, E. A., & Chiasson, D. A. (1989) · PubMed · Cited by 248
Beta-catenin signaling in murine liver zonation and regeneration: A Wnt-Wnt situation!
Yang, J., Mowry, L. E., Nejak-Bowen, K. N., Okabe, H., Diegel, C. R., Lang, R. A., Williams, B. O., & Monga, S. P. (2014) · Hepatology · doi:10.1002/hep.27082 · Cited by 244
Self-citationEdamoto, Y., Hara, A., Biernat, W., Terracciano, L., Cathomas, G., Riehle, H., Matsuda, M., Fujii, H., Scoazec, J., & Ohgaki, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11254 · Cited by 220
Epidermal Growth Factor Receptor: A Novel Target of the Wnt/β-Catenin Pathway in Liver
Tan, X., Apte, U., Micsenyi, A., Kotsagrelos, E., Luo, J.-H., Ranganathan, S., Monga, D. K., Bell, A., Michalopoulos, G. K., & Monga, S. P. S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.013 · Cited by 219
Self-citationOzawa, M., & Kemler, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6166 · Cited by 208
Tan, X., Yuan, Y., Zeng, G., Apte, U., Thompson, M. D., Cieply, B., Stolz, D. B., Michalopoulos, G. K., Kaestner, K. H., & Monga, S. P. S. (2008) · Hepatology · doi:10.1002/hep.22225 · Cited by 202
Self-citationJiang, F., Parsons, C. J., & Stefanovic, B. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.016 · Cited by 202
Yamamoto, Y., Sakamoto, M., Fujii, G., Tsuiji, H., Kenetaka, K., Asaka, M., & Hirohashi, S. (2003) · Hepatology · doi:10.1053/jhep.2003.50029 · Cited by 200
Transcription under the Control of Nuclear Arm/β-Catenin
Städeli, R., Hoffmans, R., & Basler, K. (2006) · Current Biology · doi:10.1016/j.cub.2006.04.019 · Cited by 199
Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations
Harada, N., Oshima, H., Katoh, M., Tamai, Y., Oshima, M., & Taketo, M. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2123 · Cited by 194
T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice
Gougelet, A., Torre, C., Veber, P., Sartor, C., Bachelot, L., Denechaud, P.-D., Godard, C., Moldes, M., Burnol, A.-F., Dubuquoy, C., et al. (2014) · Hepatology · doi:10.1002/hep.26924 · Cited by 190
Kim, M., Lee, H. C., Tsedensodnom, O., Hartley, R., Lim, Y.-S., Yu, E., Merle, P., & Wands, J. R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.020 · Cited by 179
Somatic mutations of the APC gene in sporadic hepatoblastomas.
Oda, H., Imai, Y., Nakatsuru, Y., Hata, J.-I., & Ishikawa, T. (1996) · PubMed · Cited by 175
Safely targeting cancer stem cells via selective catenin coactivator antagonism
Lenz, H., & Kahn, M. (2014) · Cancer Science · doi:10.1111/cas.12471 · Cited by 175
Wnt Signaling Regulates Hepatic Metabolism
Liu, H., Fergusson, M. M., Wu, J. J., Rovira, I. I., Liu, J., Gavrilova, O., Lu, T., Bao, J., Han, D., Sack, M. N., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001249 · Cited by 174
Barrott, J. J., Cash, G. M., Smith, A. P., Barrow, J. R., & Murtaugh, L. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006437108 · Cited by 174
Unique phenotype of hepatocellular cancers with exon‐3 mutations in beta‐catenin gene†
Cieply, B., Zeng, G., Proverbs‐Singh, T., Geller, D. A., & Monga, S. P. S. (2009) · Hepatology · doi:10.1002/hep.22695 · Cited by 174
Self-citationActivation of β-catenin in epithelial and mesenchymal hepatoblastomas
Wei, Y., Fabre, M., Branchereau, S., Gauthier, F., Perilongo, G., & Buendia, M.-A. (2000) · Oncogene · doi:10.1038/sj.onc.1203356 · Cited by 172
Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
Cadoret, A., Ovejero, C., Saadi-Kheddouci, S., Souil, E., Fabrè, M., Romagnolo, B., Kahn, A., & Perret, C. (2001) · PubMed · Cited by 169
Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
Amaddeo, G., Cao, Q., Ladeiro, Y., Imbeaud, S., Nault, J.-C., Jaoui, D., Gaston Mathe, Y., Laurent, C., Laurent, A., Bioulac-Sage, P., et al. (2015) · Gut · doi:10.1136/gutjnl-2013-306228 · Cited by 169
Nejak‐Bowen, K. N., Thompson, M. D., Singh, S., Bowen, W. C., Dar, M. J., Khillan, J. S., Dai, C., & Monga, S. P. (2010) · Hepatology · doi:10.1002/hep.23538 · Cited by 168
Self-citationConvergence of Wnt Signaling on the HNF4α-Driven Transcription in Controlling Liver Zonation
Colletti, M., Cicchini, C., Conigliaro, A., Santangelo, L., Alonzi, T., Pasquini, E., Tripodi, M., & Amicone, L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.038 · Cited by 168
Harada, N., Miyoshi, H., Murai, N., Oshima, H., Tamai, Y., Oshima, M., & Taketo, M. M. (2002) · PubMed · Cited by 164
A role for Wnt-4 in renal fibrosis
Surendran, K., McCaul, S. P., & Simon, T. C. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0009.2001 · Cited by 164
Aydinlik, H., Nguyen, T. D., Moennikes, O., Buchmann, A., & Schwarz, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204982 · Cited by 164
López-Terrada, D., Gunaratne, P. H., Adesina, A. M., Pulliam, J., Hoang, D. M., Nguyen, Y., Mistretta, T.-A., Margolin, J., & Finegold, M. J. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.07.022 · Cited by 163
Adenomatous polyposis coli‐deficient zebrafish are susceptible to digestive tract neoplasia
Haramis, A. G., Hurlstone, A., van der Velden, Y., Begthel, H., van den Born, M., Offerhaus, G. J. A., & Clevers, H. C. (2006) · EMBO reports · doi:10.1038/sj.embor.7400638 · Cited by 163
Legoix, P., Bluteau, O., Bayer, J., Perret, C., Balabaud, C., Belghiti, J., Franco, D., Thomas, G., Laurent-Puig, P., & Zucman-Rossi, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202800 · Cited by 162
Sekine, S., Gutiérrez, P. J. A., Lan, B. Y., Feng, S., & Hebrok, M. (2007) · Hepatology · doi:10.1002/hep.21523 · Cited by 162
c-erbB-2 Gene Product Directly Associates with β-Catenin and Plakoglobin
Kanai, Y., Ochiai, A., Shibata, T., Oyama, T., Ushijima, S., Akimoto, S., & Hirohashi, S. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1443 · Cited by 161
Sekiya, T., Adachi, S., Kohu, K., Yamada, T., Higuchi, O., Furukawa, Y., Nakamura, Y., Nakamura, T., Tashiro, K., Kuhara, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310876200 · Cited by 158
Chen, Y., Jeng, Y., Yeh, S., & Chen, P. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00099-x · Cited by 147
Shackel, N. A., McGuinness, P. H., Abbott, C. A., Gorrell, M. D., & McCaughan, G. W. (2001) · Gut · doi:10.1136/gut.49.4.565 · Cited by 143
Austinat, M., Dunsch, R., Wittekind, C., Tannapfel, A., Gebhardt, R., & Gaunitz, F. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-21 · Cited by 139
Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model
Armengol, C., Cairo, S., Fabrè, M., & Buendia, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.012 · Cited by 137
Involvement of the Tyrosine Kinase Fer in Cell Adhesion
Rosato, R. R., Veltmaat, J. M., Groffen, J., & Heisterkamp, N. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5762 · Cited by 136
Du, Q., Zhang, X., Cardinal, J. S., Cao, Z., Guo, Z., Shao, L., & Geller, D. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0014 · Cited by 133
Ihara, A. (1996) · Hepatology · doi:10.1053/jhep.1996.v23.pm0008675162 · Cited by 126
Wnt–β-catenin Signaling Protects Against Hepatic Ischemia and Reperfusion Injury in Mice
Lehwald, N., Tao, G., Jang, K. Y., Sorkin, M., Knoefel, W. T., & Sylvester, K. G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.051 · Cited by 125
Wnt Signaling and Pulmonary Fibrosis
Morrisey, E. E. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64271-x · Cited by 123
Ge, W., Wang, Y., Wu, J., Fan, J., Chen, Y., & Zhu, L. W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2099 · Cited by 122
Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma
Takagi, H., Sasaki, S., Suzuki, H., Toyota, M., Maruyama, R., Nojima, M., Yamamoto, H., Omata, M., Tokino, T., Imai, K., et al. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2170-0 · Cited by 121
(2002) · PubMed · Cited by 120
Biallelic inactivation of the APC gene in hepatoblastoma.
Kurahashi, H., Takami, K., Oue, T., Kusafuka, T., Okada, A., Tawa, A., Okada, S., & Nishisho, I. (1995) · PubMed · Cited by 120
Ovejero, C., Cavard, C., Périanin, A., Hakvoort, T., Vermeulen, J., Godard, C., Fabre, M., Chafey, P., Suzuki, K., Romagnolo, B., et al. (2004) · Hepatology · doi:10.1002/hep.20286 · Cited by 118
Beta‐catenin signaling in hepatic development and progenitors: Which way does the WNT blow?
Lade, A. G., & Monga, S. P. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22522 · Cited by 113
Self-citationShih, Y., Shyu, R., Hsieh, C., Lai, H., Liu, K., Chu, T., & Lin, Y. (2006) · Cancer · doi:10.1002/cncr.22023 · Cited by 113
Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells
Kordes, C., Sawitza, I., & Häussinger, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.085 · Cited by 113
Gebhardt, R., & Hovhannisyan, A. (2009) · Developmental Dynamics · doi:10.1002/dvdy.22041 · Cited by 112
Somatic mutations of β-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma
Jeng, Y., Wu, M., Mao, T., Chang, M., & Hsu, H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00433-4 · Cited by 111
Activation of Wnt/β‐catenin pathway during hepatocyte growth factor–induced hepatomegaly in mice†
Apte, U. M., Zeng, G., Stock, P., Tan, X., Micsenyi, A., Cieply, B. W., Dai, C., Liu, Y., Kaestner, K. H., & Monga, S. P. (2006) · Hepatology · doi:10.1002/hep.21317 · Cited by 111
Self-citationTyrosine residues 654 and 670 in β-catenin are crucial in regulation of Met–β-catenin interactions
Zeng, G., Apte, U. M., Micsenyi, A., Bell, A. W., & Monga, S. P. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.08.003 · Cited by 109
Self-citationPregnane X Receptor Activators Inhibit Human Hepatic Stellate Cell Transdifferentiation In Vitro
Shepherd, E. L., Tucker, S. J., Marek, C. J., Durward, E., Leel, V., Bascal, Z. A., Monaghan, T. M., Koruth, M., Collie-Duguid, E. S. R., Mann, D. A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.012 · Cited by 106
Rebouissou, S., Couchy, G., Libbrecht, L. J., Balabaud, C. P., Imbeaud, S., Auffray, C., Roskams, T., Bioulac‐Sage, P., & Zucman‐Rossi, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.013 · Cited by 105
Cellular and Molecular Basis of Liver Development
Shin, D., & Monga, S. P. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120022 · Cited by 103
Self-citationRole and Regulation of β-Catenin Signaling During Physiological Liver Growth
Monga, S. P. (2014) · Gene Expression · doi:10.3727/105221614x13919976902138 · Cited by 103
Self-citationDevereux, T. R., Stern, M. C., Flake, G. P., Yu, M. C., Zhang, Z., London, S. J., & Taylor, J. A. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1041 · Cited by 103
Bonvini, P., An, W. G., Rosolen, A., Nguyen, P., Trepel, J. B., de Herreros, A. G., Duñach, M., & Neckers, L. M. (2001) · PubMed · Cited by 103
β‐Catenin Accumulation and Mutation of Exon 3 of the β‐Catenin Gene in Hepatocellular Carcinoma
Kondo, Y., Kanai, Y., Sakamoto, M., Genda, T., Mizokami, M., Ueda, R., & Hirohashi, S. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00712.x · Cited by 102
Suzuki, T., Yano, H., Nakashima, Y., Nakashima, O., & Kojiro, M. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02774.x · Cited by 101
Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis
Tannapfel, A., & Wittekind, C. (2002) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-002-0617-x · Cited by 100
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma
Nambotin, S. B., Lefrançois, L., Sainsily, X., Berthillon, P., Kim, M., Wands, J. R., Chevallier, M., Jalinot, P., Scoazec, J., TREPO, C. G., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.033 · Cited by 95
High frequency of β-catenin mutations in hepatoblastoma
Udatsu, Y., Kusafuka, T., Kuroda, S., Miao, J., & Okada, A. (2001) · Pediatric Surgery International · doi:10.1007/s003830000576 · Cited by 91
Wnt signaling enhances the activation and survival of human hepatic stellate cells
Myung, S. J., Yoon, J., Gwak, G., Kim, W. K., Lee, J., Kim, K. M., Shin, C. S., Jang, J. J., Lee, S.-H., Lee, S., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.050 · Cited by 88
Gotoh, J., Obata, M., Yoshie, M., Kasai, S., & Ogawa, K. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.435 · Cited by 85
Beta-Catenin–NF-κB Interactions in Murine Hepatocytes: A Complex to Die for
Nejak‐Bowen, K. N., Kikuchi, A., & Monga, S. P. (2012) · Hepatology · doi:10.1002/hep.26042 · Cited by 83
Self-citationBello, B. D., de la Rosa, L. E. S., Campanini, N., Tinelli, C., Viera, F. T., D’Ambrosio, G., Rossi, S. M., & Silini, E. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1978 · Cited by 82
Rashid, S. T., Humphries, J. D., Byron, A., Dhar, A., Askari, J. A., Selley, J. N., Knight, D., Goldin, R. D., Thursz, M. R., & Humphries, M. J. (2012) · Journal of Proteome Research · doi:10.1021/pr3000927 · Cited by 81
Fanti, M., Singh, S., Ledda‐Columbano, G. M., Columbano, A., & Monga, S. P. (2013) · Hepatology · doi:10.1002/hep.26775 · Cited by 79
Self-citationLee, J. M., Yang, J., Newell, P., Singh, S., Parwani, A. V., Friedman, S. L., Nejak‐Bowen, K. N., & Monga, S. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.020 · Cited by 79
Self-citationHIF-2α Enhances β-Catenin/TCF-Driven Transcription by Interacting with β-Catenin
Choi, H., Chun, Y.-S., Kim, T.-Y., & Park, J.-W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0505 · Cited by 79
Liu, W., Singh, R., Choi, C. S., Lee, H., Keramati, A. R., Samuel, V. T., Lifton, R. P., Shulman, G. I., & Mani, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286724 · Cited by 78
Ip, W., Shao, W., Chiang, Y.-T. A., & Jin, T. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00249.2012 · Cited by 77
GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma
Ban, K. C., Singh, H., Krishnan, R., & Seow, H. F. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00421-x · Cited by 77
Hu, P., O’Keefe, E. J., & Rubenstein, D. S. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01523.x · Cited by 75
Conditional Disruption of Axin1 Leads to Development of Liver Tumors in Mice
Feng, G. J., Cotta, W., Wei, X., Poetz, O., Evans, R., Jardé, T., Reed, K. R., Méniel, V. S., Williams, G. T., Clarke, A. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.047 · Cited by 73
HGF/c-Met related activation of β-catenin in hepatoblastoma
Purcell, R., Childs, M., Maibach, R., Miles, C., Turner, C., Zimmermann, A., & Sullivan, M. J. (2011) · Journal of experimental & clinical cancer research : CR · doi:10.1186/1756-9966-30-96 · Cited by 71
Yuan, R., Jeng, Y., Hu, R., Lai, P., Lee, P., Cheng, C.-C., & Hsu, H. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1373-x · Cited by 69
Winer, I. S., Bommer, G. T., Gonik, N. J., & Fearon, E. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604217200 · Cited by 60
β-Catenin and Met Deregulation in Childhood Hepatoblastomas
Ranganathan, S., Tan, X., & Monga, S. P. (2005) · Pediatric and Developmental Pathology · doi:10.1007/s10024-005-0028-5 · Cited by 58
Self-citationHepatocyte γ-catenin compensates for conditionally deleted β-catenin at adherens junctions
Wickline, E. D., Awuah, P. K., Behari, J., Ross, M., Stolz, D. B., & Monga, S. P. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.014 · Cited by 56
Self-citationZhu, N., Wang, J., & Tsukamoto, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.156703 · Cited by 55
Wickline, E. D., Du, Y., Stolz, D. B., Kahn, M., & Monga, S. P. (2013) · Neoplasia · doi:10.1593/neo.122098 · Cited by 53
Self-citationβ-Catenin Regulates Vitamin C Biosynthesis and Cell Survival in Murine Liver
Nejak‐Bowen, K. N., Zeng, G., Tan, X., Cieply, B. W., & Monga, S. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047258 · Cited by 53
Self-citationDelgado, E. R., Okabe, H., Preziosi, M., Russell, J. O., Alvarado, T. F., Oertel, M., Nejak‐Bowen, K. N., Zhang, Y., & Monga, S. P. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.021 · Cited by 52
Self-citationQian, J., Sarnaik, A. A., Bonney, T. M., Keirsey, J. K., Combs, K. A., Steigerwald, K., Acharya, S., Behbehani, G. K., Barton, M. C., Lowy, A. M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.074 · Cited by 48
Delgado, E. R., Bahal, R., Yang, J., Lee, S. E., Ly, D. H., & Monga, S. P. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990081 · Cited by 44
Self-citationXiong, W., Hu, L., Jian, Y., Wang, L.-J., Jiang, M., Li, W., & He, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i15.1745 · Cited by 44
Bauer-Hofmann, R., Klimek, F., Buchmann, A., Müller, O. J., Bannasch, P., & Schwarz, M. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940060110 · Cited by 40
Identification and Characterization of a Novel Small-Molecule Inhibitor of β-Catenin Signaling
Delgado, E. R., Yang, J., So, J., Fanti, M., Leimgruber, S., Kahn, M., Ishitani, T., Shin, D., Wilson, G. M., & Monga, S. P. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.04.002 · Cited by 39
Self-citationFukuzawa, R., Hata, J., Hayashi, Y., Ikeda, H., & Reeve, A. E. (2003) · Pediatric and Developmental Pathology · doi:10.1007/s10024-003-1009-1 · Cited by 39
Hepatocellular carcinoma development induced by conditional β‐catenin activation in Lkb1+/− mice
Miyoshi, H., Deguchi, A., Nakau, M., Kojima, Y., Mori, A., Oshima, M., Aoki, M., & Taketo, M. M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01284.x · Cited by 39
Li, W., Zhu, C., Li, Y., Wu, Q., & Gao, R. (2014) · Gut and Liver · doi:10.5009/gnl.2014.8.3.282 · Cited by 38
Role of Leukocyte Cell-Derived Chemotaxin 2 as a Biomarker in Hepatocellular Carcinoma
Okabe, H., Delgado, E. R., Lee, J. M., Yang, J., Kinoshita, H., Hayashi, H., Tsung, A., Behari, J., Beppu, T., Baba, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098817 · Cited by 36
Self-citationTanaka, A., Leung, P. S. C., Kenny, T. P., Au-Young, J. K., Prindiville, T. P., Coppel, R. L., Ansari, A. A., & Gershwin, M. E. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0522 · Cited by 32
Yanagida, A., Iwaisako, K., Hatano, E., Taura, K., Sato, F., Narita, M., Nagata, H., Asechi, H., Üemoto, S., & Kinoshita, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.015 · Cited by 27
Speeding up hepatocyte proliferation: How triiodothyronine and β-catenin join forces
Gebhardt, R. (2013) · Hepatology · doi:10.1002/hep.26984 · Cited by 10
Cited by
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00762-6 · Cited by 2,519
“Wnt/β-catenin signalling pathway in non-tumour liver diseases: The cholestasis Wnt/β-catenin pathway decreases bile acid (BA) synthesis, preventing the development of cholestatic liver injury and fibrosis after bile duct ligation (BDL).(179,180) Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease that r…”
BackgroundThe regulation of β-catenin activity and function in cancer: therapeutic opportunities
Shang, S., Hua, F., & Hu, Z.-W. (2017) · Oncotarget · doi:10.18632/oncotarget.15687 · Cited by 641
Wnt–β-catenin signalling in liver development, health and disease
Perugorria, M. J., Olaizola, P., Labiano, I., Esparza-Baquer, A., Marzioni, M., Marin, J. J. G., Bujanda, L., & Banales, J. M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0075-9 · Cited by 605
Molecular and histological correlations in liver cancer
Calderaro, J., Ziol, M., Paradis, V., & Zucman-Rossi, J. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.001 · Cited by 590
The Wnt signaling pathway in cancer
Duchartre, Y., Kim, Y.-M., & Kahn, M. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.12.005 · Cited by 548
Metadata
- Authors
- Monga, S. P.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 148
- Issue
- 7
- Pages
- 1294-1310
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2100086304
- Cited by
- 487
- References
- 167
- FWCI
- 17.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.